ºÚÁú½Ê¡2022ÄêµÚÈýÅú¡°Á½Æ±ÖÆ¡±³Ðŵ֯É걨½á¹û
¡¡¡¡¸÷Ïà¹ØÆóÒµ¡¢ÓйØÒ©Æ·ÉÏÊгÖÓÐÈË£º
¡¡¡¡¸ù¾Ý¡¶¹ØÓÚ¿ªÕ¹ºÚÁú½Ê¡¹«Á¢Ò½ÁÆ»ú¹¹Ò©Æ·²É¹º“Á½Æ±ÖÆ”É걨¹¤×÷µÄ֪ͨ¡·ÒªÇó£¬ÏÖÒѶÔ2022ÄêµÚÈýÅú“Á½Æ±ÖÆ”³ÐŵÄÚÈݽøÐÐÁ˹«Ê¾£¬¾¶ÔÊÕµ½µÄ·´À¡ÄÚÈݺ˶ÔÕûÀí£¬ÏÖ½«³Ðŵ½á¹ûÓèÒÔ¹«²¼£¬²¢¶ÔµÚÒ»ÅúºÍµÚ¶þÅú²¿·ÖÄÚÈݽøÐиüÕý¡£
¡¡¡¡Ìش˹«¸æ¡£
¡¡¡¡¸½¼þ£ººÚÁú½Ê¡2022ÄêµÚÈýÅú“Á½Æ±ÖÆ”³ÐŵÄÚÈÝÃûµ¥
ÐòºÅ
|
Éú²úÆóÒµ£¨ÉÏÊгÖÓÐÈË£©
|
³ÐŵÆóÒµ
|
³ÐŵÊÂÏî
|
Ò©Æ·Ãû³Æ
|
±¸×¢
|
1
|
ºÚÁú½¾ÅÖÝͨҽҩÓÐÏÞ¹«Ë¾
|
¹þ¶û±õ»ªÃûÒ½Ò©ÓÐÏÞ¹«Ë¾
|
Èý
|
|
|
2
|
IBSA Institut Biochimique SA
|
ÖØÇìÏÈ·æÒ½Ò©ÓÐÏÞ¹«Ë¾
|
¶þ
|
×¢ÉäÓÃÄò´ÙÂÑÅݼ¤ËØ
|
|
3
|
¼ÃÄϾ°óϿƼ¼ÓÐÏÞ¹«Ë¾
|
ÖØÇìǬöÎÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
°ËÕ䯬
|
|
4
|
º£ÄÏͨÓÿµÁ¦ÖÆÒ©ÓÐÏÞ¹«Ë¾
|
½Î÷öÎÈóÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
×¢ÉäÓÃßÁÀÎ÷̹4g¡¢8g
|
|
5
|
Laboratoires Merck Sharp & Dohme Chibret
|
ÉϺ£Ä¬É³¶«Ò½Ò©Ã³Ò×ÓÐÏÞ¹«Ë¾
|
¶þ
|
×¢ÉäÓô×ËῨ²´·Ò¾»50mg¡¢70mg
|
|
6
|
ºþÄÏ¿µ¶û¼ÑÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾
|
ºþÄÏ¿µ¶û¼ÑҩƷóÒ×ÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
7
|
º£ÄÏÍòçâÖÆÒ©ÓÐÏÞ¹«Ë¾
|
º£ÄÏ¿µÈðºÍÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
ÈüÂå¶àÐÁ½ºÄÒ
|
|
8
|
¹ãÖݰ×ÔÆÉ½Ã÷ÐËÖÆÒ©ÓÐÏÞ¹«Ë¾
|
½Î÷½ð¡ҽҩÓÐÏÞ¹«Ë¾
|
ËÄ
|
ÑÌõ£°·×¢ÉäÒº£¨1ml£º100mg/1ml:50mg£©
|
|
9
|
ɽ¶«ÈóÔóÖÆÒ©ÓÐÏÞ¹«Ë¾
|
ɽ¶«ÁËδԪҽҩÏúÊÛÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
10
|
Ì«ÑôÉý£¨ÙñÖÝ£©ÉúÎïÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾
|
°²»ÕÖᦱ¦ÅµÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
±½»ÇËá°±ÂÈµØÆ½Æ¬°´C20H25ClN2O5¼Æ5mg
|
|
11
|
ɽ¶«öλÝÒ©ÒµÓÐÏÞ¹«Ë¾
|
½Î÷Á¢´ïÔÆÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
Ò¶ËáÆ¬0.4mg
|
|
12
|
ÉÂÎ÷½¡ÃñÖÆÒ©ÏÞ¹«Ë¾
|
½Î÷Á¢´ïÔÆÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
ÁòËáþעÉäÒº10ml:1g
|
|
13
|
ÄþÏĶàάҩҵÓÐÏÞ¹«Ë¾
|
ÐìÖݺèÏèÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
ÏÙÜÕîܰ·Æ¬
|
|
14
|
¹ãÖݰ×ÔÆÉ½Ã÷ÐËÖÆÒ©ÓÐÏÞ¹«Ë¾
|
Î人»ãº£Ò½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
ÑÎËáÉöÉÏÏÙËØ×¢ÉäÒº1ml:1mg
|
|
15
|
ÄÚÃɹſâÂ×ÃÉÒ©ÓÐÏÞ¹«Ë¾
|
ÖØÇ츣î£ÔµÒ½Ò©ÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
16
|
°²»ÕÓþºãÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾
|
°²»Õ¹ãÓþºãÉúÒ©ÒµÓÐÏÞ¹«Ë¾
|
ËÄ
|
°ÂÏõßò×¢ÉäÒº¡¢Ã×Á¦Å©×¢ÉäÒº¡¢·¨ÊæµØ¶û×¢ÉäÒº¡¢°±äåË÷×¢ÉäÒº
|
|
17
|
º£ÄϹãÉýÓþÖÆÒ©ÓÐÏÞ¹«Ë¾
|
¹ãÉýÓþ¿Ø¹É¼¯ÍÅÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
18
|
½ËÕ¼ÎÒÝÒ½Ò©ÓÐÏÞ¹«Ë¾
|
Î÷²ØÇªÔ´Ò©ÒµÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
19
|
ºÓ±±ÎäÂÞÒ©ÒµÓÐÏÞ¹«Ë¾
|
Î÷²Ø°î³¼Ò©Òµ¼¯ÍÅÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
20
|
ÉÂÎ÷¶ÙË¹ÖÆÒ©ÓÐÏÞ¹«Ë¾
|
Î÷²Ø°î³¼Ò©Òµ¼¯ÍÅÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
21
|
¸£½¨¹ÅÌïÒ©ÒµÓÐÏÞ¹«Ë¾
|
¹ãÖݹ㿵ҽҩÓÐÏÞ¹«Ë¾
|
ËÄ
|
άÉúËØB6×¢ÉäÒº¡¢²ñºú×¢ÉäÒº
|
|
22
|
½ËÕÉñÁúÒ©ÒµÓÐÏÞ¹«Ë¾
|
½Î÷Ô´ÃúÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
µ¤²Î×¢ÉäÒº
|
|
23
|
Dr. Willmar Schwabe GmbH & Co. KG
|
¿ÆÔ°Ð꣣¨±±¾©£©Ò½ÁÆÓÃÆ·Ã³Ò×ÓÐÏÞ¹«Ë¾
|
¶þ
|
ÂíÀõÖÖ×ÓÌáÈ¡ÎïÆ¬
|
|
24
|
ÐŶ«Éú¼¼¹É·ÝÓÐÏÞ¹«Ë¾
|
¿ÆÔ°Ð꣣¨±±¾©£©Ò½ÁÆÓÃÆ·Ã³Ò×ÓÐÏÞ¹«Ë¾
|
¶þ
|
ÑÎËáÀûÍоý×¢ÉäÒº
|
|
25
|
GLAXOSMITHKLINE MANUFACTURING SPA
|
¿ÆÔ°Ð꣣¨±±¾©£©Ò½ÁÆÓÃÆ·Ã³Ò×ÓÐÏÞ¹«Ë¾
|
¶þ
|
±½»Ç˳°¢Çú¿âï§×¢ÉäÒº
|
|
26
|
GLAXOSMITHKLINE MANUFACTURING SPA
|
¿ÆÔ°Ð꣣¨±±¾©£©Ò½ÁÆÓÃÆ·Ã³Ò×ÓÐÏÞ¹«Ë¾
|
¶þ
|
Ã׿âÂÈï§×¢ÉäÒº
|
|
27
|
SwissCo Services AG
|
¿ÆÔ°Ð꣣¨±±¾©£©Ò½ÁÆÓÃÆ·Ã³Ò×ÓÐÏÞ¹«Ë¾
|
¶þ
|
ÁòËᰬɳ¿µßò½ºÄÒ
|
|
28
|
Cilag AG
|
¿ÆÔ°Ð꣣¨±±¾©£©Ò½ÁÆÓÃÆ·Ã³Ò×ÓÐÏÞ¹«Ë¾
|
¶þ
|
×¢ÉäÓÃ˾Í×Îôµ¥¿¹
|
|
29
|
AESICA PHARMACEUTICALS S.r.l.
|
¿ÆÔ°Ð꣣¨±±¾©£©Ò½ÁÆÓÃÆ·Ã³Ò×ÓÐÏÞ¹«Ë¾
|
¶þ
|
ÑÎËáÎ÷ÌæÀûີμÁ
|
|
30
|
Õã½Ëտɰ²Ò©ÒµÓÐÏÞ¹«Ë¾
|
Õã½ÄÏÑóÒ©Æ·ÏúÊÛÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
31
|
¾ÆÈª´óµÃÀûÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾
|
Âõ¸ßÒ½Ò©£¨ºþ±±£©ÓÐÏÞ¹«Ë¾
|
Ò»
|
|
|
32
|
ɽ¶«¾©ÓùÌÃÖÆÒ©ÓÐÏÞ¹«Ë¾
|
½Î÷Ê¢¿µÒ½Ò©ÓÐÏÞ¹«Ë¾
|
ËÄ
|
ÈéøÉúƬ
|
|
|
|
|
|
|
|
¸üÕý£¨µÚÒ»Åú£©
|
¼ªÁÖÁúÌ©ÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾
|
½Î÷»Ý¿µÒ½Ò©ÏúÊÛÓÐÏÞ¹«Ë¾
|
ËÄ
|
µÆÕµ»¨ËØ×¢ÉäÒº
|
Ô±ê¼Ç³ÐŵÆóҵΪ½Î÷»Ý¿µÒ½Ò©ÏúÊÛ¹«Ë¾
|
¸üÕý£¨µÚÒ»Åú£©
|
ÉϺ£½õµÛ¾ÅÖÝÒ©Òµ£¨°²Ñô£©ÓÐÏÞ¹«Ë¾
|
½Î÷»Ý¿µÒ½Ò©ÏúÊÛÓÐÏÞ¹«Ë¾
|
ËÄ
|
Ç⻯¿ÉµÄËÉ×¢ÉäÒº
|
Ô±ê¼Ç³ÐŵÆóҵΪ½Î÷»Ý¿µÒ½Ò©ÏúÊÛ¹«Ë¾
|
¸üÕý£¨µÚ¶þÅú£©
|
ͨ»¯»Ý¿µÉúÎïÖÆÒ©ÓÐÏÞ¹«Ë¾
|
½Î÷»Ý¿µÒ½Ò©ÏúÊÛÓÐÏÞ¹«Ë¾
|
ËÄ
|
µ¤²Î×¢ÉäÒº£¨10ml£©
|
Ô±ê¼Ç³ÐŵÆóҵΪ½Î÷»Ý¿µÒ½Ò©ÏúÊÛ¹«Ë¾
|
¸üÕý£¨µÚ¶þÅú£©
|
ͨ»¯»Ý¿µÉúÎïÖÆÒ©ÓÐÏÞ¹«Ë¾
|
½Î÷»Ý¿µÒ½Ò©ÏúÊÛÓÐÏÞ¹«Ë¾
|
ËÄ
|
×¢ÉäÓôٸÎϸ°ûÉú³¤ËØ£¨20mg£©
|
Ô±ê¼Ç³ÐŵÆóҵΪ½Î÷»Ý¿µÒ½Ò©ÏúÊÛ¹«Ë¾
|
¸üÕý£¨µÚ¶þÅú£©
|
ͨ»¯»Ý¿µÉúÎïÖÆÒ©ÓÐÏÞ¹«Ë¾
|
½Î÷»Ý¿µÒ½Ò©ÏúÊÛÓÐÏÞ¹«Ë¾
|
ËÄ
|
µÆÕµ»¨ËØÆ¬£¨20Ƭ£©
|
Ô±ê¼Ç³ÐŵÆóҵΪ½Î÷»Ý¿µÒ½Ò©ÏúÊÛ¹«Ë¾
|
¸üÕý£¨µÚ¶þÅú£©
|
ɽ¶«Ò潡ҩҵÓÐÏÞ¹«Ë¾
|
½Î÷»Ý¿µÒ½Ò©ÏúÊÛÓÐÏÞ¹«Ë¾
|
Ò»
|
|
Ô±ê¼Ç³ÐŵÆóҵΪ½Î÷»Ý¿µÒ½Ò©ÏúÊÛ¹«Ë¾
|
¡¡¡¡ËµÃ÷£º1.³ÐŵÊÂÏîÐòºÅ£º
¡¡¡¡£¨Ò»£©Ò©Æ·Éú²úÆóÒµ»ò¿Æ¹¤Ã³Ò»Ì廯µÄ¼¯ÍÅÐÍÆóÒµÉèÁ¢µÄ½öÏúÊÛ±¾Æó Òµ£¨¼¯ÍÅ£©Ò©Æ·µÄÈ«×Ê»ò¿Ø¹ÉÉÌÒµ¹«Ë¾£¨È«¹ú½öÏÞ1¼ÒÉÌÒµ¹«Ë¾£©¿ÉÊÓͬÉú²úÆóÒµ¡£
¡¡¡¡£¨Èý£©Ò©Æ·Á÷ͨ¼¯ÍÅÐÍÆóÒµÄÚ²¿ÏòÈ«×Ê£¨¿Ø¹É£©×Ó¹«Ë¾»òÈ«×Ê£¨¿Ø¹É£© ×Ó¹«Ë¾Ö®¼äµ÷²¦Ò©Æ·¿É²»ÊÓΪһƱ£¬µ«×î¶àÔÊÐí¿ªÒ»´Î·¢Æ±¡£
¡¡¡¡£¨ËÄ£©Ò©Æ·ÉÏÊгÖÓÐÈËίÍдúΪÏúÊÛÒ©Æ·µÄÉú²úÆóÒµ£¨ÐèÓоӪÐí¿É ×ÊÖÊ£©»ò¾ÓªÆóÒµ¿ÉÊÓͬÉú²úÆóÒµ£¨È«¹ú½öÏÞ1¼ÒÒ©Æ·Éú²úÆóÒµ»ò¾ÓªÆóÒµ£©¡£
¡¡¡¡2.¾ßÌ广¸ñÒÔºÚÁú½Ê¡Ò©Æ·¼¯ÖвɹºÍø¹ÒÍøÄÚÈÝΪ׼
¡¡¡¡ºÚÁú½Ê¡Ò½ÁƱ£ÕÏ·þÎñÖÐÐÄ
¡¡¡¡2022Äê9ÔÂ20ÈÕ
¡¾°æÈ¨ÉùÃ÷¡¿±ü³Ð»¥ÁªÍø¿ª·Å¡¢°üÈݵľ«Éñ£¬Ò½Ò©Íø»¶Ó¸÷·½(×Ô)ýÌå¡¢»ú¹¹×ªÔØ¡¢ÒýÓÃÎÒÃÇÔ´´ÄÚÈÝ£¬µ«ÒªÑϸñ×¢Ã÷À´Ô´Ò½Ò©Íø£»Í¬Ê±£¬ÎÒÃdz«µ¼×ðÖØÓë±£»¤ÖªÊ¶²úȨ£¬Èç·¢ÏÖ±¾Õ¾ÎÄÕ´æÔÚ°æÈ¨ÎÊÌ⣬·³Ç뽫°æÈ¨ÒÉÎÊ¡¢ÊÚȨ֤Ã÷¡¢°æÈ¨Ö¤Ã÷¡¢ÁªÏµ·½Ê½µÈ£¬·¢ÓʼþÖÁpharmnet@netsun.com£¬ÎÒÃǽ«µÚһʱ¼äºËʵ¡¢´¦Àí¡£
- Ïà¹Ø±¨µÀ
-
- ¼ªÁÖÊ¡2022Äê8Ô·ݹ«Á¢Ò½ÁÆ»ú¹¹Ò©Æ·²É¹º¡°Á½Æ±ÖÆ¡±½ç¶¨½á¹û(2022-08-26)
- »Ö¸´¼ªÁÖʡҩƷ¼¯ÖвɹºÈÕ³£ÐÅÏ¢ ±ä¸ü¡¢¡°Á½Æ±ÖÆ¡±½ç¶¨ºÍÆóÒµÉ걨 È«¹ú×îµÍ¼Û¹¤×÷(2022-08-24)
- ºÓÄϹ«Ê¾Ò©Æ·¡°Á½Æ±ÖÆ¡±²ÄÁÏ£¨µÚÊ®ÆßÅú£©ÆóÒµÉ걨Çåµ¥(2022-07-11)
- ¸ÊËàÒ©Æ·¹ºÏú¡°Á½Æ±ÖÆ¡±Ò»Æ±È϶¨½á¹û¹«Ê¾(µÚ¶þʮһÅú)(2022-07-05)
- µ÷Õû¼ªÁÖʡҩƷ¼¯ÖвɹºÈÕ³£ÐÅÏ¢±ä¸ü¡¢¡°Á½Æ±ÖÆ¡±½ç¶¨ ºÍÆóÒµÉ걨ȫ¹ú×îµÍ¼Û°ìÊÂÁ÷³Ì(2022-05-31)
- 2022Äê¶È¼ªÁÖÊ¡µÚËÄÅúÒ©Æ·¼¯ÖвɹºÈÕ³£ÐÅÏ¢¸üС¢¡°Á½Æ±ÖÆ¡±½ç¶¨ ºÍÆóÒµÉ걨ȫ¹ú×îµÍ¼Û(2022-05-30)
- ºÚÁú½Ê¡2022Äê µÚÈýÅú¡°Á½Æ±ÖÆ¡±³ÐŵÄÚÈݵĹ«Ê¾(2022-05-18)
- ºÚÁú½Ê¡2022Äê µÚ¶þÅú¡°Á½Æ±ÖÆ¡±³Ðŵ֯É걨½á¹û(2022-05-18)
- 2022Äê¶È¼ªÁÖÊ¡µÚÈýÅúÒ©Æ·¼¯ÖвɹºÈÕ³£ÐÅÏ¢¸üС¢¡°Á½Æ±ÖÆ¡±½ç¶¨ ºÍÆóÒµÉ걨ȫ¹ú×îµÍ¼Û(2022-05-17)
- ºÓÄÏÔٴι«Ê¾Ò©Æ·¡°Á½Æ±ÖÆ¡±²ÄÁÏ£¨µÚÊ®ÁùÅú£©ÆóÒµÉ걨Çåµ¥(2022-04-27)
